Medicine Overview of Gliclapack MV 0.2mg/500mg/80mg Tablet
Gliclapack MV 0.2mg/500mg/80mg Tablet is used in the treatment of type 2 diabetes
Hypoglycemia (low blood sugar level), Nausea, Altered taste, Diarrhoea, Stomach pain, Flatulence, Headache, Skin rash, Upper respiratory tract infection.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Gliclapack MV 0.2mg/500mg/80mg Tablet is to be taken with food.
Gliclapack MV 0.2mg/500mg/80mg Tablet may cause stomach upset if taken empty stomach.
Gliclapack MV 0.2mg/500mg/80mg Tablet is a combination of three antidiabetic medicines: Voglibose, metformin and gliclazide.They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Voglibose is an alpha-glucosidase inhibitor which prevents breakdown of complex sugars into simple sugars such as glucose. This prevents blood glucose from rising very high after meals. Metformin is a biguanide which lowers glucose production in the liver, delays glucose absorption from intestines and increases the body's sensitivity to insulin. Gliclazide is a sulfonylurea which works by increasing the amount of insulin released by the pancreas to lower the blood glucose.
In Depth Information on Gliclapack MV 0.2mg/500mg/80mg Tablet
Gliclapack MV Tablet related warnings
Alcohol intake may increase or decrease the blood sugar lowering action in an unpredictable way
WEIGH RISKS VS BENEFITS
Gliclapack MV 0.2mg/500mg/80mg Tablet may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Gliclapack MV 0.2mg/500mg/80mg Tablet is probably safe to us
e during lactation.
Limited human data suggests that the drug does not represent a significant risk to the baby.
Your ability to drive may be affected if your blood sugar is
low or high. If this happens, do not drive.
Gliclapack MV 0.2mg/500mg/80mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Gliclapack MV 0.2mg/500mg/80mg Tablet may be needed. Please consult your doctor.
Use of Gliclapack MV 0.2mg/500mg/80mg Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Gliclapack MV 0.2mg/500mg/80mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Gliclapack MV 0.2mg/500mg/80mg Tablet may be needed. Please consult your doctor.
Gliclapack MV 0.2mg/500mg/80mg Tablet is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
One of the following vendor pharmacies will deliver Gliclapack MV 0.2mg/500mg/80mg Tablet: PVP, DGN, DPP, SSA, SWA, VRS, GTC, HBV, PWN, BSN, NSL, RHW, NXG, SDM, SAF, MDO, FGH, UMP, JVN, ANT, LCC, HIP, MAX, SBA, OHM, ATL, THP, ARD, HAT, JMJ, STA, DYG, NWP, AYU, LHA, RSA, MLC, DFP, KHH, RHL, RSS, ZVP, USF, GNC, IPL, EMB, DDR, IAD, HGI, OLT, OIP, OWP, SWP, HMP, DLP, SCH, TRP, NTB, GPP, ZEL, SJP, DHR, PTI, RPP, SAT, PRN, TNH, WSI, SHD, SGC, NDP, RJH, SYN, INC, GTK, ADT, DPL, NVY, HPC, JIV, AMR, ATP, ABP, MAM, SVH, RUS, PLT, BMJ, HEX, RWP, NVL, AAY, WHL, AGT, JVO, BDN, BAL, GPT, BHP, MMS, NNH, SBL, BBS, BTM, MSD, SHP, ENP, 9T9, MPC, AAR, BIO, GBL, MAK, PNT, EQN, MOM, RKS, AVN, PEN, CLT, PPR